ABSTRACT
Profiling the variability related to the estrous cycle is essential for assessing depressive-like behavior and screening drugs. This study compares circulating plasma corticosterone levels [CORT] and behavioral alterations in mice exposed to sucrose preference, forced swimming, and tail suspension tests (SPT, FST, and TST, respectively). While SPT exposure did not significantly alter [CORT], FST and TST showed notable changes. Mice in the TST exhibited increased movement and decreased immobility time compared to FST, suggesting a lower likelihood of depressive-like behavior in male mice. Notably, during the proestrus phase, female mice displayed the highest tendency for depressive-like behavior and elevated [CORT], but similar response to antidepressants (imipramine and fluoxetine). The inherent stress of the FST and TST tasks appears to influence [CORT] as well as depressant and antidepressant effects. These comparisons provide valuable insights for further behavioral phenotyping, model sensitivity assessment, and deepen our neurobiological understanding of depression in the context of drug screening.
Subject(s)
Antidepressive Agents , Fluoxetine , Mice , Male , Female , Animals , Antidepressive Agents/pharmacology , Fluoxetine/pharmacology , Depression/drug therapy , Imipramine/pharmacology , Behavior, Animal , Swimming , Disease Models, Animal , Corticosterone , Hindlimb SuspensionABSTRACT
Bacterial resistance is a threat to health worldwide, mainly due to reduced effective treatment. In this context, the search for strategies to control such infections and suppress antimicrobial resistance is necessary. One of the strategies that has been used is combination therapy. In the present work, we investigated the in vitro efficacy of the antimicrobials diminazene aceturate (DA), chloramphenicol (CHL), and streptomycin (STP) alone and in combination against Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus clinical isolates. DA was capable of inhibiting all strains with MIC of 25-400 µg mL-1, while STP and CHL showed antibacterial activity with minimum inhibitory concentration (MICs) of ≤3.12-400 µg mL-1. The combination of aceturate with STP showed synergism toward almost all Gram-negative bacteria, with fractional inhibitory concentration index (FICIs) of 0.09-0.37. In addition, for CHL and aceturate, synergisms for Gram-negative and -positive strains were observed. A time-kill assay against E. coli revealed that the aceturate and STP combination can inhibit bacterial growth in a shorter time when compared with single antibiotics. In addition, antimicrobials did not show hemolytic activity even at the highest concentrations used. Therefore, the antimicrobial combinations presented in this work showed important results, demonstrating that combined therapy can be used as an alternative strategy for pathogen control.
Subject(s)
Anti-Infective Agents , Chloramphenicol , Chloramphenicol/pharmacology , Streptomycin/pharmacology , Escherichia coli , Anti-Bacterial Agents/pharmacology , Bacteria , Anti-Infective Agents/pharmacology , Microbial Sensitivity TestsABSTRACT
The discovery of antibiotics was a revolutionary feat that provided countless health benefits. The identification of penicillin by Alexander Fleming initiated the era of antibiotics, represented by constant discoveries that enabled effective treatments for the different classes of diseases caused by bacteria. However, the indiscriminate use of these drugs allowed the emergence of resistance mechanisms of these microorganisms against the available drugs. In addition, the constant discoveries in the 20th century generated a shortage of new molecules, worrying health agencies and professionals about the appearance of multidrug-resistant strains against available drugs. In this context, the advances of recent years in molecular biology and microbiology have allowed new perspectives in drug design and development, using the findings related to the mechanisms of bacterial resistance to generate new drugs that are not affected by such mechanisms and supply new molecules to be used to treat resistant bacterial infections. Besides, a promising strategy against bacterial resistance is the combination of drugs through adjuvants, providing new expectations in designing new antibiotics and new antimicrobial therapies. Thus, this manuscript will address the main mechanisms of bacterial resistance under the understanding of medicinal chemistry, showing the main active compounds against efflux mechanisms, and also the application of the use of drug delivery systems, and finally, the main potential natural products as adjuvants or with promising activity against resistant strains.
Subject(s)
Bacterial Infections , Chemistry, Pharmaceutical , Humans , Bacteria , Bacterial Infections/drug therapy , Bacterial Infections/microbiology , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Drug Design , Drug Resistance, Multiple, BacterialABSTRACT
Tetracycline (TC), oxytetracycline (OTC), and chlortetracycline (CTC) interactions with the allergenic milk protein casein (CAS) were here evaluated simulating food conditions. The antibiotics assessed interact with CAS through static quenching and form non-fluorescent complexes. At 30 °C, the binding constant (Kb) varied from 0.05 to 1.23 × 106 M-1. Tetracycline interacts with CAS preferably through electrostatic forces, while oxytetracycline and chlortetracycline interactions occur by hydrogen bonds and van der Waals forces. The interaction process is spontaneous, and the magnitude of interaction based on Kb values, followed the order: TC < CTC < OTC. The distances between the donor (protein) and the receptors (TC, OTC, and CTC) were determined by Förster resonance energy transfer (FRET) and varied from 3.67 to 4.08 nm. Under natural feeding conditions, the citrate decreased the affinity between TC and CAS; a similar effect was observed for OTC in the presence of Ca(II), Fe(III) and lactose. Synchronized and three-dimensional (3D) fluorescence studies indicated alterations in the original protein conformation due to the interaction process, which may influence allergenic processes. In addition, complexation with CAS modulated the antimicrobial activity of CTC against S. aureus, demonstrated that the interaction process possibly alters the biological properties of antibiotics and the own protein, in the food conditions.Communicated by Ramaswamy H. Sarma.
Subject(s)
Allergens , Caseins , Milk Proteins , Tetracyclines , Anti-Bacterial Agents/pharmacology , Caseins/chemistry , Ferric Compounds , Staphylococcus aureus , Tetracyclines/pharmacologyABSTRACT
The search for new drugs remains an important focus for the safe and effective treatment of cardiovascular diseases. Previous evidence has shown that choline analogs can offer therapeutic benefit for cardiovascular complications. The current study investigates the effects of 2-(4-((1-phenyl-1H-pyrazol-4-yl)methyl)piperazin-1-yl)ethan-1-ol (LQFM032) on cardiovascular function and cholinergic-nitric oxide signaling. Synthesized LQFM032 (0.3, 0.6, or 1.2 mg/kg) was administered by intravenous and intracerebroventricular routes to evaluate the potential alteration of mean arterial pressure, heart rate, and renal sympathetic nerve activity of normotensive and hypertensive rats. Vascular function was further evaluated in isolated vessels, while pharmacological antagonists and computational studies of nitric oxide synthase and muscarinic receptors were performed to assess possible mechanisms of LQFM032 activity. The intravenous and intracerebroventricular administration of LQFM032 elicited a temporal reduction in mean arterial pressure, heart rate, and renal sympathetic nerve activity of rats. The cumulative addition of LQFM032 to isolated endothelium-intact aortic rings reduced vascular tension and elicited a concentration-dependent relaxation. Intravenous pretreatment with L-NAME (nitric oxide synthase inhibitor), atropine (nonselective muscarinic receptor antagonist), pirenzepine, and 4-DAMP (muscarinic M1 and M3 subtype receptor antagonist, respectively) attenuated the cardiovascular effects of LQFM032. These changes may be due to a direct regulation of muscarinic signaling as docking data shows an interaction of choline analog with M1 and M3 but not nitric oxide synthase. Together, these findings demonstrate sympathoinhibitory, hypotensive, and antihypertensive effects of LQFM032 and suggest the involvement of muscarinic receptors.
Subject(s)
Antihypertensive Agents/pharmacology , Hypotension/physiopathology , Piperazines/pharmacology , Pyrazoles/pharmacology , Receptor, Muscarinic M1/physiology , Receptor, Muscarinic M3/physiology , Animals , Aorta, Thoracic/drug effects , Aorta, Thoracic/physiology , Atropine/pharmacology , Blood Pressure/drug effects , Heart Rate/drug effects , Hypertension/chemically induced , Male , Muscarinic Antagonists/pharmacology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Piperidines/pharmacology , Pirenzepine/pharmacology , Rats, Inbred SHR , Rats, WistarABSTRACT
Faced with the global health threat of increasing resistance to antibiotics, researchers are exploring interventions that target bacterial virulence factors. Quorum sensing is a particularly attractive target because several bacterial virulence factors are controlled by this mechanism. Furthermore, attacking the quorum-sensing signaling network is less likely to select for resistant strains than using conventional antibiotics. Strategies that focus on the inhibition of quorum-sensing signal production are especially attractive because the enzymes involved are expressed in bacterial cells but are not present in their mammalian counterparts. We review here various approaches that are being taken to interfere with quorum-sensing signal production via the inhibition of autoinducer-2 synthesis, PQS synthesis, peptide autoinducer synthesis, and N-acyl-homoserine lactone synthesis. We expect these approaches will lead to the discovery of new quorum-sensing inhibitors that can help to stem the tide of antibiotic resistance.
Subject(s)
Adaptation, Physiological/drug effects , Anti-Bacterial Agents/isolation & purification , Bacteria/drug effects , Gene Expression Regulation, Bacterial/drug effects , Quorum Sensing/drug effects , Virulence/drug effects , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Bacteria/pathogenicity , Drug Evaluation, Preclinical/methods , Virulence Factors/biosynthesisABSTRACT
Enterobacter cloacae is a Gram-negative bacterium associated with high morbidity and mortality in intensive care patients due to its resistance to multiple antibiotics. Currently, therapy against multi-resistant bacteria consists of using colistin, in spite of its toxic effects at higher concentrations. In this context, colistin-resistant E. cloacae strains were challenged with lower levels of colistin combined with other antibiotics to reduce colistin-associated side effects. Colistin-resistant E. cloacae (ATCC 49141) strains were generated by serial propagation in subinhibitory colistin concentrations. After this, three colistin-resistant and three nonresistant replicates were isolated. The identity of all the strains was confirmed by MALDI-TOF MS, VITEK 2 and MicroScan analysis. Furthermore, cross-resistance to other antibiotics was checked by disk diffusion and automated systems. The synergistic effects of the combined use of colistin and chloramphenicol were observed via the broth microdilution checkerboard method. First, data here reported showed that all strains presented intrinsic resistance to penicillin, cephalosporin (except fourth generation), monobactam, and some associations of penicillin and ß-lactamase inhibitors. Moreover, a chloramphenicol and colistin combination was capable of inhibiting the induced colistin-resistant strains as well as two colistin-resistant clinical strains. Furthermore, no cytotoxic effect was observed by using such concentrations. In summary, the data reported here showed for the first time the possible therapeutic use of colistin-chloramphenicol for infections caused by colistin-resistant E. cloacae.
Subject(s)
Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacology , Colistin/pharmacology , Drug Resistance, Multiple, Bacterial , Enterobacter cloacae/drug effects , Cell Wall/drug effects , DNA, Bacterial , Gene Expression Regulation, Bacterial/drug effects , RNA, BacterialABSTRACT
OBJECTIVES: The purpose of this study was to evaluate the effect of type 2 diabetes mellitus (T2DM) on salivary function impairments according to glycemic control status and subsequently compare the concentration of chromogranin A (CHGA) with its genetic profile. MATERIALS AND METHODS: Thirty-six patients with controlled T2DM, 36 with poorly controlled T2DM, and 38 nondiabetic subjects underwent salivary flow rate measurements by means of unstimulated labial (ULS), unstimulated whole (UWS), and stimulated whole saliva (SWS) collections. CHGA concentrations were determined in saliva and plasma with ELISA, and two CHGA polymorphisms (T-415C and Glu264Asp) were analyzed by polymerase chain reaction-restriction fragment length polymorphism. RESULTS: T2DM patients presented significantly lower ULS and UWS flow rates regardless of glycemic control status compared to controls (P = 0.002 and P = 0.027, respectively). The SWS flow rate in the poorly controlled T2DM was the lowest among the groups (P = 0.026). Significantly higher plasma and salivary CHGA levels were found in T2DM groups (P = 0.019 and P < 0.001, respectively). CHGA gene variants (T-415C and Glu264Asp) revealed significant differences between diabetics and control subjects when associated with lower salivary flow and higher salivary CHGA production (P < 0.05). CONCLUSIONS: T2DM causes abnormalities in the function of salivary glands. However, poorly controlled T2DM has the most influence on SWS flow rates. Our findings indicate an association between plasma and salivary CHGA levels and T2DM patients. Furthermore, the results suggest that CGHA polymorphisms might be associated with salivary gland hypofunction and higher salivary CHGA production in T2DM patients. Nevertheless, further epidemiological studies are required to elucidate this clinical implication. CLINICAL RELEVANCE: Salivary impairments and high levels of CHGA are associated with T2DM patients. In addition, CGHA polymorphisms might be associated with salivary gland hypofunction and higher salivary CHGA production in T2DM patients. This could be a significant insight to establish a role for salivary CHGA as a potential clinical biomarker to T2DM.
Subject(s)
Chromogranin A/blood , Chromogranin A/genetics , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/physiopathology , Salivary Glands/physiopathology , Biomarkers/blood , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Middle Aged , Polymerase Chain Reaction , Polymorphism, Genetic , Polymorphism, Restriction Fragment LengthABSTRACT
OBJECTIVE: To evaluate the effect of glycemic control status in type 2 diabetes mellitus (T2DM) individuals on clinical oral health indicators and to compare the concentrations of plasma and salivary chromogranin A (CHGA) among nondiabetic subjects and T2DM patients, exploring their associations. DESIGN: In this cross-sectional study, 32 patients with controlled T2DM, 31 with poorly controlled T2DM and 37 nondiabetic subjects underwent a clinical and periodontal examination. CHGA concentrations were determined in saliva and plasma with ELISA. RESULTS: Poorly controlled T2DM group exhibited significantly higher mean buffering capacity, plaque index and bleeding on probing than other groups (P<0.05). No difference was found to DMFT (decayed, missed and filled teeth) index between groups. Sites with clinical attachment loss (CAL) of 4 and 5-6mm were significantly higher in both diabetic groups compared to control group (P<0.05). Poorly controlled T2DM group had significantly higher sites with CAL ≥ 7 mm than other groups (P=0.001). Significantly higher plasma and salivary CHGA levels were found in T2DM groups (P<0.05). In both diabetic groups, probing depths 5-6mm and CAL 5-6mm were associated with higher salivary CHGA concentration (P<0.05). CONCLUSIONS: The findings revealed that T2DM patients were more prone to periodontal tissue damage than to caries risk. The results also provide some evidence that the degree of attachment loss deteriorates significantly with poor glycemic control in T2DM (CAL ≥ 7 mm). Moreover, the results suggest that high concentrations of salivary CHGA are associated with worse periodontal parameters and T2DM, and this could be related to the pathogenesis of both diseases.
Subject(s)
Chromogranin A/metabolism , Dental Caries/metabolism , Diabetes Mellitus, Type 2/metabolism , Periodontal Diseases/metabolism , Salivary Glands/metabolism , Adult , Aged , Blood Glucose/metabolism , Body Mass Index , Chromogranin A/blood , Cross-Sectional Studies , Dental Caries/blood , Diabetes Mellitus, Type 2/blood , Female , Glycemic Index , Humans , Male , Middle Aged , Oral Health , Periodontal Diseases/bloodABSTRACT
Antimicrobial peptides (AMPs) are compounds that act in a wide range of physiological defensive mechanisms developed to counteract bacteria, fungi, parasites and viruses. These molecules have become increasingly important as a consequence of remarkable microorganism resistance to common antibiotics. This report shows Escherichia coli expressing the recombinant antimicrobial peptide Pg-AMP1 previously isolated from Psidium guajava seeds. The deduced Pg-AMP1 open reading frame consists in a 168 bp long plus methionine also containing a His6 tag, encoding a predicted 62 amino acid residue peptide with related molecular mass calculated to be 6.98 kDa as a monomer and 13.96 kDa at the dimer form. The recombinant Pg-AMP1 peptide showed inhibitory activity against multiple Gram-negative (E. coli, Klebsiella pneumonia and Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus and Staphylococcus epidermides) bacteria. Moreover, theoretical structure analyses were performed in order to understand the functional differences between natural and recombinant Pg-AMP1 forms. Data here reported suggest that Pg-AMP1 is a promising peptide to be used as a biotechnological tool for control of human infectious diseases.
Subject(s)
Anti-Bacterial Agents/pharmacology , Antimicrobial Cationic Peptides/chemistry , Antimicrobial Cationic Peptides/pharmacology , Glycine/analysis , Psidium/chemistry , Recombinant Proteins/pharmacology , Seeds/chemistry , Anti-Bacterial Agents/biosynthesis , Anti-Bacterial Agents/isolation & purification , Antimicrobial Cationic Peptides/isolation & purification , Dose-Response Relationship, Drug , Escherichia coli/drug effects , Klebsiella/drug effects , Microbial Sensitivity Tests , Models, Molecular , Pseudomonas aeruginosa/drug effects , Recombinant Proteins/biosynthesis , Recombinant Proteins/isolation & purification , Staphylococcus/drug effects , Staphylococcus aureus/drug effects , Structure-Activity RelationshipABSTRACT
Storage proteins perform essential roles in plant survival, acting as molecular reserves important for plant growth and maintenance, as well as being involved in defense mechanisms by virtue of their properties as insecticidal and antimicrobial proteins. These proteins accumulate in storage vacuoles inside plant cells, and, in response to determined signals, they may be used by the different plant tissues in response to pathogen attack. To shed some light on these remarkable proteins with dual functions, storage proteins found in germinative tissues, such as seeds and kernels, and in vegetative tissues, such as tubercles and leaves, are extensively discussed here, along with the related mechanisms of protein expression. Among these proteins, we focus on 2S albumins, Kunitz proteinase inhibitors, plant lectins, glycine-rich proteins, vicilins, patatins, tarins, and ocatins. Finally, the potential use of these molecules in development of drugs to combat human and plant pathogens, contributing to the development of new biotechnology-based medications and products for agribusiness, is also presented.
Subject(s)
Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Gene Expression Regulation, Plant/physiology , Plant Diseases/microbiology , Plant Proteins/chemistry , Plant Proteins/pharmacology , Drug Discovery , Humans , Plant Diseases/immunology , Plant Proteins/geneticsABSTRACT
Plant antibacterial peptides have been isolated from a wide variety of species. They consist of several protein groups with different features, such as the overall charge of the molecule, the content of disulphide bonds, and structural stability under environmental stress. Although the three-dimensional structures of several classes of plant peptides are well determined, the mechanism of action of some of these molecules is still not well defined. However, further studies may provide new evidences for their function on bacterial cell wall. Therefore, this paper focuses on plant peptides that show activity against plant-pathogenic and human-pathogenic bacteria. Furthermore, we describe the folding of several peptides and similarities among their three-dimensional structures. Some hypotheses for their mechanisms of action and attack on the bacterial membrane surface are also proposed.
ABSTRACT
The aroeira (Myracrodruon urundeuva Allemão) is a tropical tree with limited geographic distribution in South America, being found in drier formations such as the Cerrado and Caatinga. Empirically it is used with antiseptic, antiinflammatory, antiulcer, antidiarrhoeal and others. In this study we used mature leaves and expanded from the third and fourth nodes. Studies venation and morphology, anatomy and histochemistry were performed by the usual laboratory plant anatomy or the usual techniques of plant anatomy. For histochemical study of the fresh cuts various reagents and specific stains were used. The blade is elliptical leaflets with acute apex, oblique base, obtuse angle, entire margin and slightly wavy. Shows the pattern of venation feather-veined, pinnate type based generally asymmetrical and oblique. The indumentum is sericeous with trichomes deciduous. The consistency of the lamina is papyracea. The cuticle of leaflets, is thinner on the lower epidermis than on the upper epidermis, palisade parenchyma with a cell layer and spongy parenchyma with three cell layers with idioblasts containing crystals of CaCO3, tector trichomes simple multicellular with two or more cells are observed on both sides of the leaflets. The histochemical analysis revealed the presence of starch granules, crystals of calcium oxalate, fatty compounds, resins, phenolics and alkaloids compounds. The structural data obtained in this study may assist in ecophysiological characterization of the species and provide evidence for the identification of herbal medicines produced from that plant organ.
El "aroeira" (Myracrodruon urundeuva Allemão) es una especie de árbol tropical con una distribución geográfica limitada en América del Sur, se encuentra en formaciones más secas, como el Cerrado y Caatinga. Empíricamente se usa en la cicatrización, como anti-inflamatorio y otros. En este estudio hemos utilizado las hojas maduras y ampliadas a partir de los nodos de tercero y cuarto. Para los estudios de venación y la morfología, la anatomía y los procedimientos histoquímicos fue el laboratorio de anatomía vegetal de costumbre. Los estudios de venación y morfología, anatomía e histoquímica fueron realizados por el laboratorio habitual de Anatomía vegetal o por las técnicas usuales de la anatomía vegetal. Los folíolos son elípticos con ápice agudo, base oblicua margen de ángulo obtuso todo ligeramente ondulado. El indumento es seríceo con tricomas de hoja caduca. La consistencia de la lámina es papirácea. Muestra el patrón de venación rectinervia, tipo pinnadas basan por lo general asimétrica y oblicua. La cutícula de los folíolos, es más delgada en la epidermis inferior de la epidermis superior, parénquima en empalizada con una capa de células y el parénquima esponjoso con tres capas de células idioblastos con drusas de oxalato de calcio, tricomas tectores multicelulares simples con dos o más células en la base se observado a ambos lados del folíolo. El análisis histoquímica reveló la presencia de gránulos de almidón, cristales de oxalato de calcio, compuestos grasos, resinas, fenoles y alcaloides. Los datos estructurales obtenidos en este estudio pueden ayudar en la caracterización ecofisiológica de la especie y aportar pruebas para la identificación de los medicamentos herbarios producidos a partir de ese órgano de la planta.